Navigation Links
A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
Date:11/4/2010

BURLINGTON, Mass., Nov. 4, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed primary care physicians (PCPs) and endocrinologists indicate that—if these therapies are approved for obesity—they will prescribe Orexigen Therapeutics/Takeda's Contrave (a fixed dose combination of naltrexone and bupropion), Arena Pharmaceuticals/Eisai's Lorqess (lorcaserin) and Vivus's Qnexa (a fixed dose combination of phentermine and topiramate).

The new U.S. Physician & Payer Forum report entitled Contrave, Lorqess, and Qnexa; How Will Physician and Payer Attitudes Shape the Market for These Emerging Obesity Therapies? finds that surveyed PCPs are less likely than endocrinologists to prescribe Contrave or Lorqess but over 75 percent of both physician groups intend to prescribe Qnexa if approved. Additionally, there is little difference between the likelihood of endocrinologists to prescribe any of these three novel therapies, as approximately three quarters indicate that they intend to prescribe each of these agents for obesity.

"The obesity drug market is at an unprecedented inflection point as Contrave, Lorqess and Qnexa are attempting to enter an underserved market that is characterized by a rapidly growing patient population and very high unmet need," said Decision Resources Analyst Matthew Scutcher, Ph.D. "Meanwhile, there have been several major market challenges in recent years including the failure of Sanofi-Aventis's Acomplia (rimonabant) to gain regulatory approval in the United States and the withdrawal of Abbott's Meridia. Additionally, GlaxoSmithKline's Alli—an over-the-counter formulation of orlistat (Roche's Xenical)—has failed to bring new life to the obesity market."

The report also finds that 13 percent of surveyed clinicians and 23 percent of surveyed managed care organization's (MCO) p
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
3. Warner Chilcott Announces Early Tender Results and Receipt of Consents from a Majority of Holders of its 8-3/4% Senior Subordinated Notes due 2015
4. Majority of Surveyed Pharmacy Directors Expect To Cover Pfizers Tanezumab If It Is Approved for the Treatment of Chronic Pain
5. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
6. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
7. Martek Biosciences Announces Agreement to Sell Majority of Winchester, Ky. Manufacturing Site
8. Survey Reveals Majority of Americans Hold onto Myths About What Causes Colds and How to Treat Them
9. MultiCells Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
10. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
11. Nycomed to Accelerate Expansion in China Through Acquisition of Majority Stake in Guangdong Techpool Bio-Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
(Date:1/22/2015)... DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: RMD ... 2014. Revenue for the quarter was $423.0 million, a 10 ... (a 14 percent increase on a constant currency basis). Net ... to the quarter ended December 31, 2013. Diluted earnings per ...
(Date:1/22/2015)... 2015  Profil Institute for Clinical Research, Inc., a clinical ... today a new textbook,  Translational Research Methods for Diabetes, ... leading global scientific publisher. The textbook is ... use in early phase clinical studies of new drugs ...
Breaking Medicine Technology:TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
(Date:12/26/2014)... December 26, 2014 The US represents the ... report. In 2013, GlobalData’s forecast estimates that sales of branded ... market due to the high incidence of the disease, high ... 5EU, Japan, and China. Increased sales of CRC therapies over ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... PARK, N.J., Jan. 9 Managed Health Care,Associates, ... today,announced the addition of two outside members, Mr. ... MHA Board of Directors. Mr. Freedman and Mr.,Wheelan ... MHA,and Diamond Castle Holdings, LLC., Barry Freedman ...
... (OTC BB:ALRX -,News) stated on Tuesday that CEO Michael ... the open market, bringing the total number of,shares purchased ... confidence in the Company,s future., Mr. Michael Lee ... average price of $0.24 each, increasing his holdings to ...
... history of schizophrenia, social withdrawal among symptoms, study finds, , , ... to predict who will develop psychotic illnesses, such as schizophrenia ... new study says. , The study found five factors that ... disorder in children who were already at high risk of ...
... help simplify and refine search, SEATTLE, Jan. 9 ... an aging parent some adult children may be asking ... their loved ones., "That question often arises after ... said Eve Stern, RN, MS, president of,SNAPforSeniors, which has ...
... help employers, employees get more ... value from workplace benefits plans, COLUMBIA, S.C., ... has a new look -- and a clearer message.,Colonial Life ... tagline designed to better communicate who the company is and ...
... Jerusalem, Jan. 9. 2008 -- Two Hebrew University of ... have been awarded the 2008 Wolf Prize in Medicine ... expression and cancer research. , Minister of Education ... announced that the $100,000 prize, often referred to as ...
Cached Medicine News:Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 2Health News:MHA Announces: Managed Health Care Associates, Inc. (MHA) Expands Board of Directors 3Health News:5 Factors Help Predict Psychosis in Children 2Health News:5 Factors Help Predict Psychosis in Children 3Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 2Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 3Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 4Health News:Holiday Visits Nudge Many Towards Senior Housing Decision 5Health News:New Colonial Life Brand Clarifies Company's Strengths 2Health News:New Colonial Life Brand Clarifies Company's Strengths 3Health News:2 Hebrew University scientists awarded Wolf Prizes 2
... from medium compression weight ... provides upper back compression ... the arms. Arm length ... Wonderfabric™ unraveling. Velcro® closing ...
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
This compression garment can be used for Breast Augmentation, Augmentation Mammaplasty, Trans Umbilical Breast Augmentation, Transaxillary Submuscular Augmentation....
Provides gentle compression above and below implants...
Medicine Products: